<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Rockwell Medical Technologies Inc. | Company News & Executive Profiles - RMTI | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html?i=8]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Rockwell Medical Technologies Inc.]]></description>
	<s:counts start="0" returned="7" found="7" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Rockwell Medical's Potential for Exponential Gains]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F159566-rockwell-medical-s-potential-for-exponential-gains%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Rockwell Medical (NASDAQ:RMTI) has the potential for significant stock price gains by 2012 based on the enhanced earnings power of at least $4/share at that time for its lead clinical compound Soluble Ferric Pyrophosphate [SFP] with just a 20% share of the estimated $600 million U.S. market...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Wed, 02 Sep 2009 04:35:07 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/amag+pharmaceuticals+inc..html"><![CDATA[AMAG Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">AMAG</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">AMAG,RMTI</category>
	</item>
	<item>
		<title><![CDATA[Rockwell Medical: SFP Is Key to Future Earnings Power]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F152380-rockwell-medical-sfp-is-key-to-future-earnings-power%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Rockwell Medical Technologies (NASDAQ:RMTI) is a small-cap bio-pharmaceutical company with a core, growing business which manufactures, sells, and distributes dialysate which remove toxins and wastes from the blood while replacing nutrients products to patients with chronic kidney disease CKD and end-stage renal disease ESRD receiving dialysis (which...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Jul 2009 01:06:08 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">RMTI</category>
	</item>
	<item>
		<title><![CDATA[Update on Rockwell Medical's Phase 2b Trial]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F134181-update-on-rockwell-medical-s-phase-2b-trial%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: Rockwell Medical (NASDAQ:RMTI) announced yesterday that patient enrollment is completed for the Company's ongoing Phase 2b dose-ranging study for its iron replacement therapy soluble ferric pyrophosphate SFP. Below is the entry from RMTI in the BioMedReports.com Clinical Trial Calendar database: RMTI is developing a water soluble iron...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 30 Apr 2009 12:45:47 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">RMTI</category>
	</item>
	<item>
		<title><![CDATA[Rockwell Medical Technologies: Improving Margins, Banking on SFP]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F127955-rockwell-medical-technologies-improving-margins-banking-on-sfp%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Mike Havrilla submits: In mid-March, Rockwell Medical Technologies RMTI reported 4Q and FY08 results which included revenue of $13.5M (up 13.3% from year-ago quarter) and $51.6M (up 20% compared to 2007). The net losses were ($3M) and ($7.9M) for 4Q and FY08, respectively. Despite solid sales growth, RMTI has posted...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 26 Mar 2009 03:31:15 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/mike+havrilla.html"><![CDATA[Mike Havrilla]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">RMTI</category>
	</item>
	<item>
		<title><![CDATA[Rockwell Medical Technologies, Inc. Q3 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14046_23-249128.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator instructions We&#8217;ll have our first question from Todd Lewis [ph], South Street Capital [ph]. Todd Lewis &#8211; South Street Capital Hey, guys. Good quarter. Thanks for taking my call. Just a quick question for you. You mentioned the potential for SFP extensions and opportunities in...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 13 Nov 2008 17:41:13 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sfp.html"><![CDATA[SFP]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/sfp.html"><![CDATA[SFP]]></category>
		<category domain="http://resources.bnet.com/topic/marketing+research.html"><![CDATA[Marketing Research]]></category>
		<category domain="http://resources.bnet.com/topic/marketing.html"><![CDATA[Marketing]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">RMTI</category>
	</item>
	<item>
		<title><![CDATA[Rockwell Medical Technologies, Inc. Receives Nasdaq Notification of Continued Nasdaq Listing]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_July_12/ai_76483301]]></link>
		<description><![CDATA[Business Editors  WIXOM, Mich.--BUSINESS WIRE--July 12, 2001  Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative hemodialysis concentrate manufacturer in the healthcare industry, announced today that it has been notified by Nasdaq that the Company has demonstrated compliance with Nasdaq's listing requirements and that the Company's common stock will...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 12 Jul 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell.html"><![CDATA[Rockwell]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">NDAQ,RMTI</category>
	</item>
	<item>
		<title><![CDATA[Rockwell Medical Technologies, Inc. Receives Nasdaq Staff Determination]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2001_May_15/ai_74525145]]></link>
		<description><![CDATA[Business Editors & Health/Medical Writers  WIXOM, Mich.--BUSINESS WIRE--May 15, 2001  Rockwell Medical Technologies, Inc. (Nasdaq:RMTI), a leading, innovative hemodialysis concentrate manufacturer in the healthcare industry, said today that it received a Nasdaq Staff Determination on May 8, 2001, that the Company does not comply with the $1.00 minimum...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 15 May 2001 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell.html"><![CDATA[Rockwell]]></category>
		<category domain="http://resources.bnet.com/topic/rockwell+medical+technologies+inc..html"><![CDATA[Rockwell Medical Technologies Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">RMTI</category>
		<category domain="tickers">NDAQ,RMTI</category>
	</item>
</channel>
</rss>
